ENDRA Life Net Worth
ENDRA Life Net Worth Breakdown | NDRA |
ENDRA Life Net Worth Analysis
ENDRA Life's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including ENDRA Life's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of ENDRA Life's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform ENDRA Life's net worth analysis. One common approach is to calculate ENDRA Life's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares ENDRA Life's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing ENDRA Life's net worth. This approach calculates the present value of ENDRA Life's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of ENDRA Life's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate ENDRA Life's net worth. This involves comparing ENDRA Life's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into ENDRA Life's net worth relative to its peers.
Enterprise Value |
|
To determine if ENDRA Life is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding ENDRA Life's net worth research are outlined below:
| ENDRA Life Sciences generated a negative expected return over the last 90 days | |
| ENDRA Life Sciences has high historical volatility and very poor performance | |
| ENDRA Life Sciences has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (10.06 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| ENDRA Life Sciences currently holds about 11.28 M in cash with (9.55 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.18. | |
| ENDRA Life Sciences has a poor financial position based on the latest SEC disclosures | |
| Latest headline from MacroaxisInsider: Disposition of 34900 shares by Wells David R. of ENDRA Life at 0.9 subject to Rule 16b-3 |
ENDRA Life uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in ENDRA Life Sciences. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to ENDRA Life's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 12th of March 2024 Upcoming Quarterly Report | View | |
| 31st of December 2023 Next Fiscal Quarter End | View |
ENDRA Life Target Price Consensus
ENDRA target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. ENDRA Life's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
| One | Strong Buy |
Most ENDRA analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand ENDRA stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of ENDRA Life Sciences, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice Exposure ValuationENDRA Life Target Price Projection
ENDRA Life's current and average target prices are 4.03 and 2,625, respectively. The current price of ENDRA Life is the price at which ENDRA Life Sciences is currently trading. On the other hand, ENDRA Life's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.Target Price
Analyst Consensus On ENDRA Life Target Price
Know ENDRA Life's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as ENDRA Life is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading ENDRA Life Sciences backward and forwards among themselves. ENDRA Life's institutional investor refers to the entity that pools money to purchase ENDRA Life's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Xtx Topco Ltd | 2024-09-30 | 0.0 | Hrt Financial Llc | 2024-09-30 | 0.0 | Ubs Group Ag | 2024-12-31 | 95.0 | Morgan Stanley - Brokerage Accounts | 2024-12-31 | 13.0 | Bank Of America Corp | 2024-12-31 | 4.0 | Sassicaia Capital Advisers Llc | 2024-09-30 | 0.0 | Susquehanna International Group, Llp | 2024-09-30 | 0.0 | Jane Street Group Llc | 2024-09-30 | 0.0 | Goss Wealth Management Llc | 2024-09-30 | 0.0 | Northern Trust Investments N A | 2024-12-31 | 0.0 | Vanguard Group Inc | 2024-09-30 | 0.0 |
Follow ENDRA Life's market capitalization trends
The company currently falls under 'Nano-Cap' category with a current market capitalization of 2.12 M.Market Cap |
|
Project ENDRA Life's profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (1.34) | (1.41) | |
| Return On Capital Employed | (1.62) | (1.70) | |
| Return On Assets | (1.34) | (1.41) | |
| Return On Equity | (1.60) | (1.68) |
When accessing ENDRA Life's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures ENDRA Life's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of ENDRA Life's profitability and make more informed investment decisions.
Please note, the presentation of ENDRA Life's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, ENDRA Life's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of ENDRA Life's management manipulating its earnings.
Evaluate ENDRA Life's management efficiency
ENDRA Life Sciences has return on total asset (ROA) of (0.624) % which means that it has lost $0.624 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (1.4945) %, meaning that it created substantial loss on money invested by shareholders. ENDRA Life's management efficiency ratios could be used to measure how well ENDRA Life manages its routine affairs as well as how well it operates its assets and liabilities. As of March 21, 2025, Return On Tangible Assets is expected to decline to -1.41. In addition to that, Return On Capital Employed is expected to decline to -1.7. At present, ENDRA Life's Non Current Assets Total are projected to increase significantly based on the last few years of reporting. The current year's Non Currrent Assets Other is expected to grow to about 3.9 M, whereas Total Assets are forecasted to decline to about 6.6 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 0.72 | 0.68 | |
| Tangible Book Value Per Share | 0.72 | 0.68 | |
| Enterprise Value Over EBITDA | -3.1 K | -3.2 K | |
| Price Book Value Ratio | 6.8 K | 6.5 K | |
| Enterprise Value Multiple | -3.1 K | -3.2 K | |
| Price Fair Value | 6.8 K | 6.5 K | |
| Enterprise Value | 13.6 B | 19.4 B |
The strategic initiatives led by ENDRA Life's management are central to its market success. By analyzing these initiatives, we provide a clear picture of the stock's growth prospects.
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific ENDRA Life insiders, such as employees or executives, is commonly permitted as long as it does not rely on ENDRA Life's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases ENDRA Life insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
ENDRA Life Corporate Filings
| 14th of February 2025 Other Reports | ViewVerify | |
8K | 22nd of November 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
| 21st of November 2024 Other Reports | ViewVerify | |
10Q | 19th of November 2024 Quarterly performance report mandated by Securities and Exchange Commission (SEC), to be filed by publicly traded corporations | ViewVerify |
ENDRA Life Earnings Estimation Breakdown
The calculation of ENDRA Life's earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of ENDRA Life is estimated to be -415.275425 with the future projection ranging from a low of -415.275425 to a high of -415.275425. Please be aware that this consensus of annual earnings estimates for ENDRA Life Sciences is based on EPS before non-recurring items and includes expenses related to employee stock options.Last Reported EPS
-415.28 Lowest | Expected EPS | -415.28 Highest |
ENDRA Life Earnings Projection Consensus
Suppose the current estimates of ENDRA Life's value are higher than the current market price of the ENDRA Life stock. In this case, investors may conclude that ENDRA Life is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and ENDRA Life's stock will quickly adjusts to the new information provided by the consensus estimate.
| Number of Analysts | Historical Accuracy | Last Reported EPS | Estimated EPS for 31st of December 2024 | Current EPS (TTM) | |
| 1 | 67.44% | -9.54 | -415.275425 | -105.78 |
ENDRA Life Earnings per Share Projection vs Actual
Actual Earning per Share of ENDRA Life refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering ENDRA Life Sciences predict the company's earnings will be in the future. The higher the earnings per share of ENDRA Life, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.ENDRA Life Estimated Months Earnings per Share
For an investor who is primarily interested in generating an income out of investing in entities such as ENDRA Life, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of ENDRA Life should always be considered in relation to other companies to make a more educated investment decision.ENDRA Quarterly Analyst Estimates and Surprise Metrics
Earnings surprises can significantly impact ENDRA Life's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
2024-11-12 | 2024-09-30 | -1.78 | -9.54 | -7.76 | 435 | ||
2024-08-22 | 2024-06-30 | -3.5 | -4.0 | -0.5 | 14 | ||
2024-05-14 | 2024-03-31 | -0.27 | -0.26 | 0.01 | 3 | ||
2024-03-28 | 2023-12-31 | -0.36 | -0.05 | 0.31 | 86 | ||
2023-11-14 | 2023-09-30 | -0.43 | -0.4 | 0.03 | 6 | ||
2023-08-14 | 2023-06-30 | -0.55 | -0.43 | 0.12 | 21 | ||
2023-05-15 | 2023-03-31 | -1.04 | -0.93 | 0.11 | 10 | ||
2023-03-14 | 2022-12-31 | -0.9 | -0.96 | -0.06 | 6 | ||
2022-11-14 | 2022-09-30 | -1.1 | -1.0 | 0.1 | 9 | ||
2022-08-15 | 2022-06-30 | -1.1 | -1.2 | -0.1 | 9 | ||
2022-05-12 | 2022-03-31 | -1.5 | -1.4 | 0.1 | 6 | ||
2022-03-30 | 2021-12-31 | -1.6 | -1.6 | 0.0 | 0 | ||
2021-11-15 | 2021-09-30 | -1.5 | -1.2 | 0.3 | 20 | ||
2021-08-12 | 2021-06-30 | -1.4 | -1.6 | -0.2 | 14 | ||
2021-05-17 | 2021-03-31 | -1.5 | -1.2 | 0.3 | 20 | ||
2021-03-25 | 2020-12-31 | -2.9 | -2.0 | 0.9 | 31 | ||
2020-11-16 | 2020-09-30 | -3.47 | -3.0 | 0.47 | 13 | ||
2020-08-14 | 2020-06-30 | -5.4 | -4.0 | 1.4 | 25 | ||
2020-05-14 | 2020-03-31 | -6.7 | -5.8 | 0.9 | 13 | ||
2020-03-26 | 2019-12-31 | -5.75 | -24.0 | -18.25 | 317 | ||
2019-11-13 | 2019-09-30 | -6.05 | -9.2 | -3.15 | 52 | ||
2019-08-08 | 2019-06-30 | -6.2 | -6.2 | 0.0 | 0 | ||
2019-05-14 | 2019-03-31 | -6 | -7.4 | -1.4 | 23 | ||
2017-06-21 | 2017-03-31 | 0 | -0.19 | -0.19 | 0 |
ENDRA Life Corporate Management
| Michael Thornton | Chief Officer | Profile | |
| Renaud Maloberti | Chief Commercial Officer | Profile | |
| Ziad Rouag | Head Affairs | Profile | |
| Jonathan Behr | CoFounder | Profile | |
| Richard Jacroux | Chief Officer | Profile |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in ENDRA Life Sciences. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ENDRA Life. If investors know ENDRA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ENDRA Life listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of ENDRA Life Sciences is measured differently than its book value, which is the value of ENDRA that is recorded on the company's balance sheet. Investors also form their own opinion of ENDRA Life's value that differs from its market value or its book value, called intrinsic value, which is ENDRA Life's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ENDRA Life's market value can be influenced by many factors that don't directly affect ENDRA Life's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ENDRA Life's value and its price as these two are different measures arrived at by different means. Investors typically determine if ENDRA Life is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ENDRA Life's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.